Adderall [Bioanalytics]

posted by jag009  – NJ, 2012-05-22 23:31 (4755 d 07:34 ago) – Posting: # 8607
Views: 3,084

Hi Everyone,

As per FDA, BE studies for Mixed Amphetamine (Adderall, Adderall XR) requires measurement of both D- and L-amphetamine in the plasma. What about the requirement of 5% difference in relative potency (total Assay) between test and reference product? Does one have to demonstrate that on both D and L forms of amphetamine?

Thanks

John

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,678 registered users;
112 visitors (0 registered, 112 guests [including 9 identified bots]).
Forum time: 07:05 CEST (Europe/Vienna)

If you want to get people to believe
something really, really stupid,
just stick a number on it.    Charles Seife

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5